CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 33 filers reported holding CLOVIS ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $459,000 | – | 459 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Jabre Capital Partners S.A. | 3,500,000 | $2,732,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,721,000 | $6,769,000 | 0.82% |
| CAMDEN ASSET MANAGEMENT L P /CA | 32,275,000 | $24,949,000 | 0.70% |
| PFM Health Sciences, LP | 57,632,000 | $44,730,000 | 0.66% |
| Partner Investment Management, L.P. | 768,000 | $596,000 | 0.46% |
| SYMPHONY ASSET MANAGEMENT LLC | 1,000,000 | $776,000 | 0.21% |
| SSI INVESTMENT MANAGEMENT LLC | 3,000,000 | $2,319,000 | 0.18% |
| PointState Capital LP | 12,000,000 | $9,342,000 | 0.12% |
| MIZUHO SECURITIES USA LLC | 2,000,000 | $1,548,000 | 0.12% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,000,000 | $1,546,000 | 0.11% |